5ECE

Tankyrase 1 with Phthalazinone 1

Summary for 5ECE

• Entry DOI: 10.2210/pdb5ece/pdb
• Descriptor: Tankyrase-1, 1,2-ETHANEDIOL, 2-[4-[3-[(4-oxidanylidene-3~{H}-phthalazin-1-yl)methyl]phenyl]carbonylpiperazin-1-yl]pyridine-3-carbonitrile, ... (6 entities in total)
• Functional Keywords: tankyrase, inhibitor, parp, centrosome clustering, oncology, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• Biological source: Homo sapiens (Human)
• Cellular location: Cytoplasm: O95271
• Total number of polymer chains: 4
• Total formula weight: 99328.87

Authors

Kazmirski, S.L.,Johannes, J.,Read, J.A.,Howard, T.,Larsen, N.A.,Ferguson, A.D. (deposition date: 2015-10-20, release date: 2015-11-25, Last modification date: 2024-03-06)

• Primary citation: Johannes, J.W.,Almeida, L.,Daly, K.,Ferguson, A.D.,Grosskurth, S.E.,Guan, H.,Howard, T.,Ioannidis, S.,Kazmirski, S.,Lamb, M.L.,Larsen, N.A.,Lyne, P.D.,Mikule, K.,Ogoe, C.,Peng, B.,Petteruti, P.,Read, J.A.,Su, N.,Sylvester, M.,Throner, S.,Wang, W.,Wang, X.,Wu, J.,Ye, Q.,Yu, Y.,Zheng, X.,Scott, D.A.; Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering.; Bioorg.Med.Chem.Lett., 25:5743-5747, 2015; PubMed: 26546219; DOI: 10.1016/j.bmcl.2015.10.079

Experimental method

X-RAY DIFFRACTION (2.2 Å)